| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 10/14/2004 | WO2004087760A1 Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions |
| 10/14/2004 | WO2004087047A2 Mutants of replication competent vaccinia virus |
| 10/14/2004 | US20040204581 Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immonogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens |
| 10/14/2004 | US20040203039 Attenuated salmonella SP12 mutants as antigen carriers |
| 10/14/2004 | US20040203020 Self-replicating RNA molecule from hepatitis C virus |
| 10/14/2004 | US20040202999 for drug screening treatments for human immunodeficiency virus (HIV), cancer; gene therapy; long terminal repeat sequences; genetic engineering |
| 10/14/2004 | US20040202679 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 10/14/2004 | US20040202663 Therapy for primary and metastatic cancers |
| 10/13/2004 | EP1465987A2 Production of viruses, viral isolates and vaccines |
| 10/13/2004 | EP1102858B1 Cell lines for the propagation of mutated herpes viruses |
| 10/13/2004 | EP0595838B1 Tumor rejection antigen precursors, tumor rejection antigens and uses thereof |
| 10/13/2004 | CN1537162A Attenuated circovirus |
| 10/13/2004 | CN1536085A Construction of human hepatocyte growth factor gene recomginant retroviral vector |
| 10/13/2004 | CN1536077A High-yield recombinant influenza B virus strain and its application |
| 10/13/2004 | CN1170927C Method for producing medicine using silkworm expressed numan epidermal growth factor |
| 10/12/2004 | US6803041 Chemically inactivated ehv-1 kya virus; and an adjuvant which includes cross-linked olefinically unsaturated carboxylic acid polymer. |
| 10/07/2004 | WO2004085660A2 Improved alphavirus replicons and helper constructs |
| 10/07/2004 | WO2004085659A2 Mutant vesicular stomatitis viruses and uses thereof |
| 10/07/2004 | WO2004085658A1 Mutant vesicular stomatitis viruses and use thereof |
| 10/07/2004 | WO2004085634A2 Infectious bursal disease virus mutants and vaccines |
| 10/07/2004 | WO2004048402B1 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 10/07/2004 | WO2004046319A3 Bacteriophage having modified holin and uses thereof |
| 10/07/2004 | WO2003029431A3 Nanoscaling ordering of hybrid materials using genetically engineered mesoscale virus |
| 10/07/2004 | US20040197914 Viral delivery systems and related manufacture and use |
| 10/07/2004 | US20040197866 library can be used to select and screen for new monoclonal antibodies, and to optimize; genetic engineering |
| 10/07/2004 | US20040197351 Avian herpesvirus-based recombinant Infectious Bursal Disease vaccine |
| 10/07/2004 | US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 10/07/2004 | US20040197348 Enhanced immune response to attachment (G) protein of respiratory Syncytial virus |
| 10/07/2004 | CA2520053A1 Infectious bursal disease virus mutants and vaccines |
| 10/06/2004 | EP1463822A2 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 10/06/2004 | EP1463805A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 10/06/2004 | EP1463409A2 Gene delivery system and methods of use |
| 10/06/2004 | EP1272652B1 Herpes viruses for immune modulation |
| 10/06/2004 | EP1108050B1 Methods and compositions for expressing heterologous genes in hepatocytes using hepadnaviral vectors |
| 10/06/2004 | EP1012295B1 Alphavirus rna replicon systems |
| 10/06/2004 | EP0941240B1 New picornaviruses, vaccines and diagnostic kits |
| 10/06/2004 | EP0876498B1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv |
| 10/06/2004 | EP0862643B1 Accessory functions for use in recombinant aav virion production |
| 10/06/2004 | EP0833934B1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 10/06/2004 | EP0573611B9 Improved epitode displaying phage |
| 10/06/2004 | CN1535157A West nile vaccine |
| 10/06/2004 | CN1169949C Preparation of recombination adenovirus construction body with deletion E1A code sequence and its use |
| 10/05/2004 | US6800475 Used as a vector for gene therapy or as a recombinant virus vaccine; pathogenicity studies; screening for spumavirus infection |
| 10/05/2004 | US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 10/05/2004 | US6800289 Strain of the western equine encephalitis virus |
| 10/05/2004 | US6800288 Recombinant ns gene of influenza a virus comprising a functional rna binding domain and a sequence modification of the ns1 gene segment which bars transcription of the remaining portion of that segment; vaccines |
| 09/30/2004 | WO2004083418A1 Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby |
| 09/30/2004 | WO2004083397A2 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 09/30/2004 | WO2004083390A2 Virulent systemic feline calicivirus |
| 09/30/2004 | WO2004050843A3 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making |
| 09/30/2004 | WO2004044004A3 T cell receptor display |
| 09/30/2004 | WO2003102021A3 Cotton rat lung cells for virus culture |
| 09/30/2004 | WO2003049703A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 09/30/2004 | US20040191909 Glycerol viral suspension absent of divalent metal cations or alkali metal cations and capable for presevation and storage of adenovirus particles |
| 09/30/2004 | US20040191762 Method for purification of viral vectors having proteins which bind sialic acid |
| 09/30/2004 | US20040191272 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 09/30/2004 | CA2518926A1 Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby |
| 09/30/2004 | CA2518924A1 Process for increasing rsv surface glycoprotein yields using a mutant strain of rsv |
| 09/30/2004 | CA2513458A1 Virulent systemic feline calicivirus |
| 09/29/2004 | EP1461441A1 Flavivirus vaccine delivery system |
| 09/29/2004 | EP1461424A2 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding |
| 09/29/2004 | EP0989999B1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 09/29/2004 | EP0956045B1 Assembly-deficient herpesvirus vaccine |
| 09/29/2004 | CN1533434A Inflenza vaccine composition |
| 09/29/2004 | CN1533433A Method for virus propagation |
| 09/29/2004 | CN1168502C Porcine circovirus and parvovirus vaccine |
| 09/29/2004 | CN1168500C Method for generating bi-RNA-virus from synthetic RNA transcripts |
| 09/28/2004 | US6797506 Useful as animal vaccine (birds and humans) and for gene therapy; comprises heat shock proteins |
| 09/28/2004 | US6797505 Adeno-associated expression vector coding polypeptide for use in the treatment of blood disorders |
| 09/28/2004 | US6797462 For determining host hiv titer, drug sensitivity, hiv amplification, gene sequencing and co-receptor utilization |
| 09/28/2004 | US6797265 Therapy for metabolism disorders; gene therapy |
| 09/23/2004 | WO2004081178A2 Methods and composition for producing infectious hpv stocks |
| 09/23/2004 | WO2004055166A3 Multi-antigenic alphavirus replicon particles and methods |
| 09/23/2004 | WO2003102157A3 Synthetic antibody phage libraries |
| 09/23/2004 | WO2003096969A3 Novel lambda phage display system and the process |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | WO2003011209A8 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 09/23/2004 | US20040185565 High throughput system for producing recombinant viruses using site-specific recombination |
| 09/23/2004 | US20040185555 Viral vector coding lymphadenopathy associated antigens and devoid of early gene sequences for transfer and expression of heterologous gene sequences; vaccine development |
| 09/23/2004 | US20040185460 kits for drug screening by gel-shift assay, western blot, phage-based expression cloning, co-fractionation by chromatography, co-precipitation, cross linking, interaction trap/two hybrid analysis, and enzyme linked immunosorbent assay (ELISA) |
| 09/23/2004 | US20040185435 Molecular sequence of swine retrovirus and methods of use |
| 09/23/2004 | US20040185056 Vaccines containing bovine herpesvirus 1 attenuated by mutation in latency-related gene |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458856A1 Isolated phages and their use in food or pet food products |
| 09/22/2004 | EP1458851A1 An avian embryo particulate biomass for the production of virus antigens |
| 09/22/2004 | EP0587805B2 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 09/22/2004 | CN1531596A Methods for stable transduction of cells with viral vectors |
| 09/21/2004 | US6794188 Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells and therapeutic uses thereof |
| 09/21/2004 | US6794174 Full-length infectious cDNA clones of tick borne flavivirus |
| 09/21/2004 | US6794163 Methods to culture circovirus |
| 09/21/2004 | US6794162 Phage-dependent super-production of biologically active protein and peptides |
| 09/21/2004 | CA2195668C Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 09/16/2004 | WO2004079015A1 Method of detecting escherichia coli and phage for detecting escherichia coli |
| 09/16/2004 | WO2004078986A1 Infectious flavivirus pseudo-particles containing functional prm and/or e proteins |
| 09/16/2004 | WO2004078955A1 Animal-free cell culture method |
| 09/16/2004 | WO2004078912A2 Chicken rna polymerase i promoter and the use thereof |
| 09/16/2004 | WO2004078778A2 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (cMet) AND USES THEREOF |
| 09/16/2004 | WO2004052278A3 Escape mutants of newcastle disease virus as marker vaccines |
| 09/16/2004 | WO2004042031A3 Safer attenuated virus vaccines with missing or diminished latency of infection |
| 09/16/2004 | WO2003026690A9 Incapacitated whole-cell immunogenic bacterial compositions |